Imatinib Mesylate 400Mg Capsule ( DrugBank: Imatinib )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 89 | リンパ脈管筋腫症 | 1 |
89. リンパ脈管筋腫症
臨床試験数 : 38 / 薬物数 : 38 - (DrugBank : 15) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 118
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03131999 (ClinicalTrials.gov) | January 23, 2018 | 24/4/2017 | LAM Pilot Study With Imatinib Mesylate | LAM Pilot Study With Imatinib Mesylate | Lymphangioleiomyomatosis | Drug: Imatinib Mesylate 400Mg Capsule;Drug: Placebo - Capsule | Medical University of South Carolina | Columbia University | Completed | 18 Years | N/A | All | 18 | Phase 1/Phase 2 | United States |